Revenue Breakdown
Composition ()
No data
Revenue Streams
Smith & Nephew PLC (SNN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Sports Medicine Joint Repair, accounting for 17.1% of total sales, equivalent to $483.00M. Other significant revenue streams include Knee Implants and Advanced Wound Care. Understanding this composition is critical for investors evaluating how SNN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Smith & Nephew PLC maintains a gross margin of 70.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 14.86%, while the net margin is 9.90%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SNN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SNN competes directly with industry leaders such as BAX and QGEN. With a market capitalization of $14.18B, it holds a leading position in the sector. When comparing efficiency, SNN's gross margin of 70.62% stands against BAX's 34.39% and QGEN's 62.51%. Such benchmarking helps identify whether Smith & Nephew PLC is trading at a premium or discount relative to its financial performance.
